Teva Pharmaceutical Industries | TEVA - Operating Profit

Stock Price
9,087.00
Daily Change
-203.00 -2.19%
Monthly
-13.70%
Yearly
53.06%
Q1 Forecast
9,016.87

Teva Pharmaceutical Industries reported $487M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Aspen Pharmacare ZAR 2.72B 2.07B Jun/2025
Cipla INR 9.77B 6.21B Dec/2025
Dr.Reddys Laboratories INR 13.94B 2.31B Dec/2025
Guangzhou Baiy CNY 1.34B 548.31M Sep/2025
Jiangsu Hengrui CNY 1.41B 1.4B Sep/2025
Kalbe Farma IDR 851.77B 208.4B Sep/2025
Richter Gedeon HUF 63.58B 132M Sep/2025
Sh Fosun Pharma CNY 758.38M 67.22M Sep/2025
Sun Pharmaceuticals INR 33.67B 49.9M Sep/2025
Teva Pharmaceutical Industries USD 487M 581M Dec/2025